UK - The Capital Fund invests £250,000 to support Plasticell

The funding follows on from a recent investment of £440,000 from the company's existing shareholders and a £1.1m grant from the Department for Trade and Industry's Technology Programme in January. Plasticell, which holds intellectual property rights for two complementary systems in the fields of stem cell research and regenerative medicine, intends to use the new capital to continue ongoing product development.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• UK / Ireland